Literature DB >> 34421388

A public health response to a newly diagnosed case of hepatitis C associated with lapse in Infection Prevention and Control practices in a dental setting in Ontario, Canada.

Cassandra Johnston1, Vidya Sunil1, Dorothea Ser1, Anne Marie Holt1, Gary Garber2,3, Liane Macdonald2,4, Erik Kristjanson2, Tony Mazzulli2,4,5, Romy Olsha2, David Ryding2, Avis Lynn Noseworthy1.   

Abstract

BACKGROUND: Haliburton, Kawartha, Pine Ridge District Health Unit (HKPRDHU) investigated an exposure in an Ontario operatory dental facility related to a newly diagnosed hepatitis C virus (HCV) infection caused by a virus with an uncommon hepatitis C genotype. Lapses in Infection Prevention and Control (IPAC) and a second epidemiologically-linked case (with the same uncommon hepatitis C genotype) were identified, prompting a broader public health response and outbreak investigation.
OBJECTIVES: a) To describe the investigation of a newly diagnosed case of hepatitis C; b) to describe the broader public health response, and c) to address a paucity in the literature related to the risk of disease transmission in dental settings due to IPAC lapses.
METHODS: A collaborative approach with two dental practices, public health partners and regulatory bodies was used. An IPAC inspection was completed to determine and mitigate the risk of blood borne infection transmission within the facilities. Appropriate protocols were followed for the IPAC investigation and public health response.
RESULTS: The investigation identified a risk of potential HCV transmission between two cases linked to the same dental facility. There were no other epi-linked cases of HCV identified. Challenges included a lack of adherence to IPAC standards in one of the dental settings and awareness in the dental community regarding HCV transmission, coordination with regulatory bodies and public health experts and low uptake of laboratory testing by patients.
CONCLUSION: Despite the unique challenges associated with the investigation, HKPRDHU conducted a successful IPAC lapse investigation and public health response. Public health units need to maintain collaborative approaches with regulated health professionals, their regulatory bodies and public health experts.

Entities:  

Keywords:  IPAC; dental; hepatitis C; lapse; transmission

Year:  2021        PMID: 34421388      PMCID: PMC8340669          DOI: 10.14745/ccdr.v47i78a08

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  6 in total

1.  Rapid genotyping of hepatitis C virus by primer-specific extension analysis.

Authors:  Nick A Antonishyn; Vivian M Ast; Ryan R McDonald; Rabindra K Chaudhary; Lisa Lin; Anton P Andonov; Greg B Horsman
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

2.  Confirmed transmission of hepatitis C in an oral surgery office.

Authors:  Joel M Weaver
Journal:  Anesth Prog       Date:  2014

3.  Transmission of blood-borne pathogens in US dental health care settings: 2016 update.

Authors:  Jennifer L Cleveland; Shellie Kolavic Gray; Jennifer A Harte; Valerie A Robison; Anne C Moorman; Barbara F Gooch
Journal:  J Am Dent Assoc       Date:  2016-05-24       Impact factor: 3.634

4.  Distribution of hepatitis C virus genotypes in Canada: Results from the LCDC Sentinel Health Unit Surveillance System.

Authors:  R Chaudhary; M Tepper; S Eisaadany; P R Gully
Journal:  Can J Infect Dis       Date:  1999-01

5.  Patient Notification Events Due to Syringe Reuse and Mishandling of Injectable Medications by Health Care Personnel-United States, 2012-2018: Summary and Recommended Actions for Prevention and Response.

Authors:  Melissa K Schaefer; Kiran M Perkins; Joseph F Perz
Journal:  Mayo Clin Proc       Date:  2019-12-26       Impact factor: 7.616

6.  Public health response to a large-scale endoscopy infection control lapse in a nonhospital clinic.

Authors:  Jacqueline Willmore; Edward Ellis; Vera Etches; Lise Labrecque; Carla Osiowy; Anton Andonov; Cameron McDermaid; Anna Majury; Camille Achonu; Maurica Maher; Brenda MacLean; Isra Levy
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 Mar-Apr       Impact factor: 2.471

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.